THE INNOVATIVE MEDICINES INITIATIVE
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
Introducing the new IMI logo
The launch of the IMI 2 programme marks the beginning of a new and exciting chapter in the IMI story, and it is in this spirit that we decided the time had come to freshen up the IMI logo and our broader corporate identity.
- 15/10/2014 : RT @EFPIA: @GuyVerhofstadt "The EU should encourage public-private partnerships in research". @IMI_JU #healthyeu http://t.co/hSlb00wsnl
- 09/10/2014 : IMI 2 Call 2 indicative text now online http://t.co/mrmP75WkAo #CNS #diabetes #neuropsychiatry #vaccines #pertussis #patients
- 09/10/2014 : RT @Eu2P: Interested by Eu2P online training programmes in #pharmacovigilance? Make sure online learning is for you: http://t.co/6QaOe7VlHd